Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Kim Dora who has been jointly awarded a 2018 Orloff Science Award by the National Heart, Lung and Blood Insitute (NHLBI) at the NIH in the USA. Kim was honored for her collaborative project with Dr Robert Balaban, Chief of the Laboratory of Cardiac Energetics at NHLBI, on the ‘Permeability
of Artery Walls’

Similar stories

Rosalind Franklin Institute and Pharmacology announce strategic partnership in Next Generation Chemistry

The Rosalind Franklin Institute and the University of Oxford’s Department of Pharmacology have entered into a strategic partnership for Next Generation Chemistry.

New insight into the pharmacology of a therapeutic ion channel target

A new paper, published by the Tammaro lab in the Proceedings of the National Academy of Sciences (PNAS), shines new light on potential sites for pharmacological intervention within TMEM16A channels.

J Harold Burn (1892-1981)

A world-leading pharmacologist who built up the Department

New BHF study offers potential of new clinical options for cardiac treatment

A new study, led by Professor Kim Dora in association with Professor Raimondo Ascione at the University of Bristol, has shown abnormalities in the tiny blood vessels of human hearts which cannot be detected by current heart scans. Poor myogenic (automatic) tone, where blood flow in these vessels is abnormal, is thought to develop independent of disease in the larger arteries, which can be treated using stents or bypass surgeries.